These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8632517)

  • 1. In vitro competitive inhibition of plasma cholinesterase by cocaine: normal and variant genotypes.
    Schwartz HJ; Johnson D
    J Toxicol Clin Toxicol; 1996; 34(1):77-81. PubMed ID: 8632517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
    Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hepatectomy and plasma cholinesterase inhibition on cocaine metabolism and cardiovascular responses in pigs.
    Kambam JR; Franks JJ; Mets B; Janicki PK; Hickman R; van der Watt M
    J Lab Clin Med; 1994 Nov; 124(5):715-22. PubMed ID: 7964130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of plasma cholinesterase variants using the dibutyrate analogue of pancuronium bromide.
    Whittaker M; Britten JJ
    Hum Hered; 1981; 31(4):242-7. PubMed ID: 7287015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the plasma cholinesterase variants by propranolol.
    Whittaker M; Britten JJ; Wicks RJ
    Br J Anaesth; 1981 May; 53(5):511-6. PubMed ID: 7236476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in human plasma cholinesterase activity during low-dose cocaine administration.
    Hoffman RS; Thompson T; Henry GC; Hatsukami DK; Pentel PR
    J Toxicol Clin Toxicol; 1998; 36(1-2):3-9. PubMed ID: 9541034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mipafox differential inhibition assay for heart muscle cholinesterases: substrate specificity and inhibition of three isoenzymes by physostigmine and quinidine.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Gen Pharmacol; 1997 Apr; 28(4):567-75. PubMed ID: 9147026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scope and limitations of propionylthiocholinesterase in the characterisation of cholinesterase variants.
    Price EM; Brown SS
    Clin Biochem; 1975 Dec; 8(6):384-90. PubMed ID: 1204213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.
    Carmona GN; Jufer RA; Goldberg SR; Gorelick DA; Greig NH; Yu QS; Cone EJ; Schindler CW
    Drug Metab Dispos; 2000 Mar; 28(3):367-71. PubMed ID: 10681384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cholinergic receptors and cholinesterase activity in hemodynamic responses to cocaine in conscious rats.
    Knuepfer MM; Gan Q
    Am J Physiol; 1999 Jan; 276(1):R103-12. PubMed ID: 9887183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine.
    Berkman CE; Underiner GE; Cashman JR
    Biochem Pharmacol; 1997 Dec; 54(11):1261-6. PubMed ID: 9416977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of plasma cholinesterase in rabbit and evaluation of the inhibitory potential of diazinon.
    Oropesa AL; Pérez-López M; Soler F
    Ecotoxicol Environ Saf; 2014 Feb; 100():39-43. PubMed ID: 24433789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new succinylcholine-based assay of plasma cholinesterase.
    Abernethy MH; George PM; Melton VE
    Clin Chem; 1984 Feb; 30(2):192-5. PubMed ID: 6362911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interlaboratory study of the proficiency of cholinesterase phenotyping.
    Evans RT; Wardell J; Rapier C
    Clin Chem; 1983 May; 29(5):786-8. PubMed ID: 6839454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an electrometric blood cholinesterase measurement in goats.
    Al-Jobory MM; Mohammad FK
    J Vet Sci; 2005 Dec; 6(4):299-303. PubMed ID: 16293993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of nutrition on plasma cholinesterase activity and cocaine toxicity in mice.
    Cahill-Morasco R; Hoffman RS; Goldfrank LR
    J Toxicol Clin Toxicol; 1998; 36(7):667-72. PubMed ID: 9865234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 19. The characteristics of the inhibition of serum cholinesterase by metoclopramide.
    Graham SG; Crossley AW
    Eur J Clin Pharmacol; 1995; 48(3-4):225-8. PubMed ID: 7589045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of anticholinesterase activity in reversible inhibitors of cholinesterase hydrolysis].
    Brestkin AP; Kuznetsova LP; Rozengart EV
    Ukr Biokhim Zh (1978); 1994; 66(1):66-72. PubMed ID: 7974841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.